Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer

Oncogene

Volumn 19, Issue 4, 2000, Pages 490-497

  Newman, Simon P ^a   Bates, Nicholas P ^a   Vernimmen, Douglas ^a   Parker, Malcolm G ^b   Hurst, Helen C ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Breast cancer; ERBB2; Oestrogen receptor; SRC 1; Transcriptional repression

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA; ESTROGEN; ESTROGEN RECEPTOR; MUTANT PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2;

ARTICLE; BINDING SITE; BREAST CANCER; CONTROLLED STUDY; ENHANCER REGION; GENE REPRESSION; HORMONAL REGULATION; INTRON; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN DNA BINDING;

EID: 0034719406     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203416     Document Type: Article

References (46)

1. Antoniotti S, Tavema D, Maggiora P, Sapei ML, Hynes NE and DeBortoli M. (1994). Br. J. Cancer, 70, 1095-1101.
2. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM and Meltzer PS. (1997). Science, 277, 965-968.
3. Bates NP and Hurst HC. (1997). Oncogene, 15, 473-481.
4. Benbrook DM and Jones NC. (1994). Nucleic Acids Res., 22, 1463-1469.
5. Berns EMJJ, Vanstaveren IL, Klijn JGM and Foekens JA. (1998). Br. Cancer Res. Treat., 48, 87-92.
6. Bevan CL, Hoare S, Claessens F, Heery DM and Parker MG. (1999). Mol. Cell. Biol., 19, 8383-8392.
7. Bocco JL, Bahr A, Goetz J, Hauss C, Kallunki T, Kedinger C and Chatton B. (1996). Oncogene, 12, 1971-1980.
8. Bosher JM, Williams T and Hurst HC. (1995). Proc. Natl. Acad. Sci. USA, 92, 744-747.
9. Bosher JM, Totty NF, Hsuan JJ, Williams T and Hurst HC. (1996). Oncogene, 13, 1701-1707.
10. Bouchard L, Lamarre L, Tremblay PJ and Jolicoeur P. (1989). Cell, 57, 931-936.
11. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA and Carlquist M. (1997). Nature, 389, 753-758.
12. Caelles C, Gonzalezsancho JM and Munoz A. (1997). Genes Dev., 11, 3351-3364.
13. Carey M. (1998). Cell, 92, 5-8.
14. Chatton B, Bocco JL, Goetz J, Gaire M, Lutz Y and Kedinger C. (1994). Oncogene, 9, 375-385.
15. Danielian PS, White R, Lees JA and Parker MG. (1992). EMBO J., 11, 1025-1033.
16. Dati C, Antoniotti S, Tavema D, Perroteau I and De Bortoli M. (1990). Oncogene, 5, 1001-1006.
17. Di Fiore PP, Pierce JH, Kraus MH, Segatto O, King CR, and Aaronson SA. (1987). Science, 237, 178-182.
18. D'Souza B, Berdichevsky F, Kyprianou N and Taylor-Papadimitriou J. (1993). Oncogene, 8, 1797-1806.
19. Gee JMW, Robertson JFR, Ellis IO, Nicholson RI and Hurst HC. (1999). J. Pathol., 189, 514-520.
20. Heery DM, Kalkhoven E, Hoare S and Parker MG. (1997). Nature, 387, 733-736.
21. Hollywood DP and Hurst HC. (1993). EMBO J., 12, 2369-2375.
22. Hurst HC. (1996). In: Protein Profiles, 3. Sheterline P (ed.). Academic Press: London.
23. Hurst HC, Masson N, Jones NC and Lee KAW. (1990). Mol. Cell. Biol., 10, 6192-6203.
24. Kalkhoven E, Valentine JE, Heery DM and Parker MG. (1998). EMBO J., 17, 232-243.
25. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK and Rosenfeld MG. (1996). Cell, 85, 403-414.
26. Kim HJ, Kim JH and Lee JW. (1998). J. Biol. Chem., 273, 28564-28567.
27. Lahooti H, White R, Danielian PS and Parker MG. (1994). Mol. Endocrinol., 8, 182-188.
28. Lee SK, Kim HJ, Na SY, Kim TS, Choi HS, Im SY and Lee JW. (1998). J. Biol. Chem., 273, 16651-16654.
29. Lee K-F, Simon H, Chen H, Bates B, Hung M-C and Hauser C. (1995). Nature, 378, 394-398.
30. Livingstone C, Patel G and Jones NC. (1995). EMBO J., 14, 1785-1797.
31. Marchionni MA. (1995). Nature, 378, 334-335.
32. McKenna NJ, Lanz RB and O'Malley BW. (1999). Endocrine Reviews, 20, 321-344.
33. Merika M, Williams AJ, Chen G, Collins T and Thanos D. (1998). Mol. Cell., 1, 277-287.
34. Na SY, Lee SK, Han SJ, Choi HS, Im SY and Lee JW. (1998). J. Biol. Chem., 273, 10831-10834.
35. Nass SJ, Hahm HA and Davidson NE. (1998). Nature Medicine, 4, 761-762.
36. Newby JC, Johnston SRD, Smith IE and Dowsett M. (1997). Clin. Cancer Res., 3, 1643-1651.
37. Onate SA, Tsai SY, Tsai MJ and O'Malley BW. (1995). Science, 270, 1354-1357.
38. Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pegram MD, Ramos L, Gorman CM, Parker MG, Sliwkowski MX and Slamon DJ. (1995). Oncogene, 10, 2435-2446.
39. Read LD, Keith D, Slamon DJ and Katzenellenbogen BS. (1990). Cancer Res., 50, 3947-3951.
40. Revillion F, Bonneterre J and Peyrat JP. (1998). Eur. J. Cancer, 34, 791-808.
41. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL. (1987). Science, 235, 177-182.
42. Saatcioglu F, Claret FX and Karin M. (1994). Semin. Cancer Biol., 5, 347-359.
43. Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK and Rosenfeld MG. (1997). Nature, 387, 677-684.
44. Turner BC, Zhang, Gumbs AA, Maher MG, Kaplan L, Carter D, Glazer PM, Hurst HC, Haffty BC and Williams T. (1998). Cancer Res., 58, 5466-5472.
45. Voegel JJ, Heine MJ, Zechel C, Chambon P and Gronemeyer H. (1996). EMBO J., 15, 3667-3675.
46. Warri AM, Laine AM, Majasuo KE, Alitalo KK and Harkonen PL. (1991). Int. J. Cancer, 49, 616-623.